Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:07 PM
Ignite Modification Date:
2025-12-24 @ 4:07 PM
NCT ID:
NCT01919866
Eligibility Criteria:
Inclusion Criteria:
* patients with primary refractory or relapsed disease (including relapse after previous SCT and active disease)
* AML in complete remission of refractory
* MDS RAEB-t/secondary AML
* ALL
* CML
* Non-Hodgkin Lymphoma / Hodgkin Lymphoma
* non malignant diseases (aplastic anemia, thalassemia, SCID)
* relapsed Neuroblastoma
* relapsed soft tissue sarcoma (Rhabdomyosarcoma, Ewing sarcoma, PNET
* soft tissue sarcoma with primary bone metastases or bone marrow
* in whom no matched donor was available,
Exclusion Criteria:
* \< 6 months after previous HSCT
* active cerebral seizure conditions
* massive progression of leukemias or solid tumours before planned trp.
* left ventricular ejection fraction \<25%
* creatinine clearance \<40ml/min before conditioning
* respiratory insufficiency with oxygen demand or DLCO \<30%
* Bilirubin \>4mg/dl, GOT/GPT \>400
* severe infection (HIV, Aspergillosis)
* pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
25 Years
Study:
NCT01919866
Study Brief:
Protocol Section:
NCT01919866